BioSpace News Archive

Genetown

Albireo to Participate in Guggenheim Nantucket Therapeutics Conference

Albireo Pharma, Inc. announced participation in the Guggenheim Therapeutics Conference in Nantucket, MA, from September 27-29, 2022.

September 20, 2022
·
1 min read
Genetown

Elicio Therapeutics Receives $2.8 Million Grant from the Gastro-Intestinal Research Foundation (GIRF) to Fund Research for Two Therapeutic Cancer Vaccines

Elicio Therapeutics announced that it has been awarded a $2.8 million grant from the Gastro-Intestinal Research Foundation in Chicago to fund research for two therapeutic cancer vaccines.

September 20, 2022
·
7 min read
Biotech Bay

Eargo Announces Proxy Solicitation for 2022 Annual Meeting; Launch of Proxy Solicitation Web Site

Eargo, Inc. announced that it had begun its proxy solicitation for the 2022 Annual Meeting of the Stockholders to be held on Wednesday, October 12, 2022 at 11 A.M. Pacific Time.

September 20, 2022
·
11 min read
Business

Pasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors

Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of new and effective treatments for central nervous system disorders, announced that Alfred J. Novak was appointed to its Board of Directors.

September 20, 2022
·
3 min read
Policy

Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Ireland

Alimera Sciences, Inc. announces that Alimera Sciences Europe Limited, its Ireland-based European subsidiary, has been granted reimbursement for ILUVIEN ® 0.19 mg sustained release intravitreal implant for non-infectious uveitis affecting the posterior segment in Ireland.

September 20, 2022
·
5 min read
Business

Humacyte Expands Board of Directors and Leadership Team with New Appointments

Humacyte, Inc. announced the appointments of two distinguished healthcare professionals to the Company’s Board of Directors and leadership team.

September 20, 2022
·
6 min read
Pharm Country

Electrocore Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced its plans to hold its fiscal year 2022 annual meeting of stockholders on Friday, December 2, 2022.

September 20, 2022
·
6 min read
BioMidwest

MIMEDX Announces Launch of AXIOFILL™

MiMedx Group, Inc., a transformational placental biologics company, announced the launch of AXIOFILL™, an Extracellular Matrix Particulate product derived from human placental tissue.

September 20, 2022
·
4 min read
Drug Development

Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine

Moat Biotechnology Corporation announces promising initial Phase I trial results of an intranasal COVID-19 vaccine, and kicks off an initial round of funding with lead investor Cortado Ventures.

September 20, 2022
·
5 min read
BioMidwest

Medical 21 secures up to $20 million commitment for its pioneering cardiac bypass technology

Medical 21, a medtech company aiming to transform heart bypass surgery with a revolutionary artificial graft, says it has successfully closed a $20 million commitment pursuant to Regulation D, Rule 506 under the Securities Act of 1933, as amended, to implement its business plan.

September 20, 2022
·
4 min read